BiVictriX Therapeutics Plc (BVX.L) LSE

10.00

+1.5(+17.65%)

Updated at September 10, 2024 06:29PM

Currency In GBp

Valuation

Market Cap7.63M
Enterprise Value4.61M
P/E Ratio-2.85
PEG Ratio-0.03
Price/Sales Ratio0
Price/Book Ratio2.05
Enterprise/Revenue0
Enterprise/EBITDA-1.83

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.59
Return On Equity-0.68

Income Statement

Revenue0
Revenue/Share0
Gross Profit-165,000
EBITDA-2.86M
Net Income-2.55M
Diluted EPS-0.04

Balance Sheet

Total Cash1.69M
Total Cash/Share0.05
Total Debt203,000
Total Debt/Equity0.07
Current Ratio6.12
Book Value Per Share0.05

Price History

52-Week Change-20
52-Week High14
52-Week Low10
Moving Average 50 Days10.91
Moving Average 200 Days10.73

Statistics

Average Volume198,581
Shares Outstanding82.53M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A